Clinical Study to Evaluate Qurs-e-Zayabitus Khas and Qurs-e-Tabasheer Over Metformin in Type-2 Diabetes Mellitus

Phase 2

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2019/04/018670
• Lead Sponsor: Central Research Institute of Unani Medicine Hyderabad

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients of any sex aged 30-65 years

Fasting plasma glucose levels between 126 and 175 mg/dL

or

Post Prandial plasma glucose levels between 200 and 250 mg/dL

(2 hours after ingestion of 75 gm of glucose in 300 ml of water)

or

HbA1c level between 6.5 and 8%

and

Presence of any of the following symptoms and signs of diabetes mellitus

(2 hours after ingestion of 75 gm of glucose in 300 ml of water)

or

HbA1c level between 6.5 and 8%

and

Presence of any symptoms and signs of diabetes mellitus

Exclusion Criteria

Subjects with FPG level >175 mg/dL and/ or PP plasma glucose level >250 mg/dL and/ or HbA1c >8%

Subjects on Insulin therapy

Type 2 DM with complications/ Secondary DM/Type 1 DM

Significant pulmonary/ cardiovascular/ hepato-renal dysfunction

Known cases of immunocompromised states (HIV/ AIDS, etc.)/ Malignancies

Obese subjects (BMI >30)

Pregnant and lactating women

Drug addicts/Alcoholics

Patient not willing to attend treatment schedule regularly

Study & Design

• Study Type: Interventional
• Study Design: Not specified